Pneumococcal Vaccines for Adults: What's Next?

Daniel M Weinberger¹, Eugene D Shapiro^{1

2}

Affiliations

¹ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
² Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.

Comment

Daniel M Weinberger et al. Clin Infect Dis. 2020.

. 2020 Jun 10;70(12):2493-2495.

doi: 10.1093/cid/ciz743.

Daniel M Weinberger¹, Eugene D Shapiro^{1

2}

¹ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
² Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Keywords: pneumococcus; pneumonia; public policy; vaccines.

Comment on

Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions-United States.
Ahmed SS, Pondo T, Xing W, McGee L, Farley M, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Rowlands J, Bennett N, Petit S, Barnes M, Smelser C, Beall B, Whitney CG, Pilishvili T. Ahmed SS, et al. Clin Infect Dis. 2020 Jun 10;70(12):2484-2492. doi: 10.1093/cid/ciz739. Clin Infect Dis. 2020. PMID: 31402387